News & Blog

FDA Grants Fast Track Designation to ANPD001, Autologous Investigational Cell Therapy for the Treatment of Parkinson’s Disease

Nobias Therapeutics Announces Acceptance of Late-Breaking Abstract and Presentation of Phase 2 Clinical Data for NB-001 at 52nd Child Neurology Society Annual Meeting

AVILAR THERAPEUTICS TO PRESENT AT UPCOMING INDUSTRY CONFERENCES

Aspen Neuroscience to Partner with Rune Labs and Emerald Innovations to Incorporate both Active and Passive Digital Health Monitoring in Trial Ready Cohort Screening Study

Aspen Neuroscience Announces FDA Clearance of Investigational New Drug Application for ANPD001, Autologous Cell Therapy for the Treatment of Parkinson’s Disease

The LP and The Biotech VC

Why Join a Biotech Startup?

WSJ: New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer

Spinning Out? A few things to consider.

BioWorld: Truvian’s blood testing platform provides lab quality results